Phase 3 Readout~month
Phase 3 Topline: A Phase 3 Randomized Study Comparing JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therap
- Drug
- eflornithine HCl
- Indication
- Multiple Myeloma
Other upcoming events for FLNA
Phase 2 StartPhase 2 Start: A Multicenter, Open-label, Randomized Controlled Clinical Study Comparing the Efficacy and Safety of
Phase 3 ReadoutPhase 3 Topline: Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates
Phase 3 ReadoutPhase 3 Topline: Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Ve
Phase 3 ReadoutPhase 3 Topline: Non-Steroidal Anti-Inflammatory Drugs Versus Conventional Treatment in Acute Myocarditis (INFLAMA Tr
Phase 3 ReadoutPhase 3 Topline: Improving EveNt Free Survival by Optimizing FLUdarabine Exposure During LymphodepletioN for CAR T CE
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.